| Quartile 1 (3-7 ng/mL) n = 71 | Quartile 2 (8-10 ng/mL) n = 58 | Quartile 3 (11-15 ng/mL) n = 65 | Quartile 4 (16-36 ng/mL) n = 63 | P value |
---|---|---|---|---|---|
Serum 25OHD, ng/mL, mean ± SD | 5.2 ± 1.7 | 9.0 ± 0.8 | 12.6 ± 1.4 | 21.9 ± 5.2 |  |
Age at surgery, years | 64 ± 15 | 66 ± 13 | 65 ± 12 | 65 ± 10 | 0.76*1 |
Gender, % female | 41 | 43 | 34 | 26 | 0.18*2 |
Stage, % | Â | Â | Â | Â | 0.78*2 |
Stage I | 21 | 17 | 18 | 24 | Â |
Stage II | 23 | 31 | 37 | 22 | Â |
Stage III | 35 | 32 | 31 | 35 | Â |
Stage IV | 21 | 20 | 14 | 19 | Â |
Location of tumor,% | Â | Â | Â | Â | 0.24*2 |
Proximal colon | 38 | 44 | 40 | 27 | Â |
Distal colon | 32 | 19 | 18 | 23 | Â |
Rectum | 30 | 37 | 42 | 50 | Â |
Type of resection, % | Â | Â | Â | Â | 0.84*2 |
R0 | 76 | 79 | 82 | 81 | Â |
R1 | 9 | 10 | 8 | 4 | Â |
R2 | 15 | 11 | 10 | 15 | Â |
Number of lymph nodes with metastasis | 2.2 ± 4.0 | 3.0 ± 6.8 | 2.2 ± 4.0 | 1.6 ± 3.0 | 0.87*3 |
Time period of surgery | Â | Â | Â | Â | < 0.001*2 |
May 2003 - December 2005 | 27 | 43 | 55 | 65 | Â |
January 2006 - January 2008 | 73 | 57 | 45 | 35 | Â |